Breast cancer
Breast cancer is one of the most common malignant tumors in women, with an incidence rate of 7-10% of all malignant tumors in the body, second only to uterine cancer in women, and has become a major cause of threat to women's health. Its onset is often related to genetics, and the incidence rate is higher in women between the ages of 40 and 60, before and after menopause. It is one of the most common malignant tumors that usually occurs in breast glandular epithelial tissue, seriously affecting women's physical and mental health and even endangering their lives. Breast cancer in men is rare, with only about 1-2% of breast patients being male.
-
Site of disease:
breast -
Infectious :
Not contagious -
Frequent population:
Women aged 45-55, late menopause, over... -
Related symptoms:
Breast lumps Distant metastasis of breast cancer A palpable lump deep in the areola Swelling of axillary lymph nodes A peanut-sized lump on the lateral edge of the pectoralis major -
Concurrent disease:
Related Drugs
Vindesine Sulfate for Injection
Indication: It is effective against malignant tumors such as non-small cell lung cancer, small cell lung cancer, malignant lymphoma, breast cancer, esophageal cancer and malignant melanoma.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Vindesine Sulfate for Injection
Indication: It is effective against malignant tumors such as non-small cell lung cancer, small cell lung cancer, malignant lymphoma, breast cancer, esophageal cancer and malignant melanoma.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Manufacturer:
Tonghua Mao Xiang Pharmaceutical Co., Ltd.
Tegafur Tablets
Indication: It is mainly used to treat digestive tract tumors, and has certain effects on gastric cancer, colon cancer, and rectal cancer. It can also be used to treat breast cancer, bronchial lung cancer, liver cancer, etc. It can also be used for bladder cancer, prostate cancer, kidney cancer, etc.
Manufacturer:
Hebei BRIC Pharmaceutical Co., Ltd.
Leuprorelin Acetate Microspheres for Injection
Indication: 1. Endometriosis; 2. For uterine fibroids accompanied by menorrhagia, lower abdominal pain, back pain and anemia, it can reduce the size of the fibroids and/or improve the symptoms; 3. Premenopausal breast cancer and estrogen receptor-positive patients; 4. Prostate cancer; 5. Central precocious puberty.
Leuprorelin Acetate Microspheres for Injection
Indication: 1. Endometriosis; 2. For uterine fibroids accompanied by menorrhagia, lower abdominal pain, back pain and anemia, it can reduce the size of the fibroids and/or improve the symptoms; 3. Premenopausal breast cancer and estrogen receptor-positive patients; 4. Prostate cancer; 5. Central precocious puberty.
Mitoxantrone Hydrochloride and Glucose Injection
Indication: Used for malignant lymphoma, breast cancer and various acute leukemias.
DOCETAXEL- docetaxel_injection, solution
Indication: Docetaxel Injection is a microtubule inhibitor indicated for: Breast Cancer (BC): 1. 1 Non-small Cell Lung Cancer (NSCLC): 1. 2 Castration-Resistant Prostate Cancer (CRPC): 1. 3 Gastric Adenocarcinoma (GC): 1. 4 Squamous Cell Carcinoma of the Head and Neck (SCCHN): 1. 5 Docetaxel Injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Docetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Docetaxel Injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Docetaxel Injection in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer who have not previously received chemotherapy for this condition. Docetaxel Injection in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer. Docetaxel Injection in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for advanced disease. Docetaxel Injection in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Manufacturer:
Hospira, Inc.
Related Ingredients